These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15128011)

  • 1. Hormone replacement therapy and risk of malignancy.
    Diamanti-Kandarakis E
    Curr Opin Obstet Gynecol; 2004 Feb; 16(1):73-8. PubMed ID: 15128011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cancer risk.
    Mahavni V; Sood AK
    Curr Opin Oncol; 2001 Sep; 13(5):384-9. PubMed ID: 11555717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on benefits and risks of hormone replacement therapy.
    Burkman RT; Collins JA; Greene RA
    Am J Obstet Gynecol; 2001 Aug; 185(2 Suppl):S13-23. PubMed ID: 11521118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
    Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
    Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making decisions about hormone replacement therapy.
    Rymer J; Wilson R; Ballard K
    BMJ; 2003 Feb; 326(7384):322-6. PubMed ID: 12574048
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
    Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
    Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.
    Persson I
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):357-64. PubMed ID: 11162945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies.
    Kim S; Ko Y; Lee HJ; Lim JE
    Breast Cancer Res Treat; 2018 Aug; 170(3):667-675. PubMed ID: 29713854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.